Likewise, PI3K/AKT induction resulting from EV-mediated transfer of platelet-derived growth factor receptor-beta (PDGFR-β) has been shown to be responsible for melanoma resistance to the BRAF inhibitor PLX4720 [34]. This evidence concerns the gene PDGFRB and melanoma.